Immanuel Thangaraj
Director · ACURA PHARMACEUTICALS, INC
Individual
- 2026
- Jan 15, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Immanuel Thangaraj's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Immanuel Thangaraj?
Immanuel Thangaraj is a corporate insider, tracked as Director of ACURA PHARMACEUTICALS, INC (ACUR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Immanuel Thangaraj last file a Form 4?
The only primary Form 4 on record is dated 15 January 2026.
